Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up

Br J Haematol. 2018 Jun;181(5):693-695. doi: 10.1111/bjh.14681. Epub 2017 Apr 2.

¹ Department of Molecular Biotechnologies and Health Sciences, Division of Haematology, University of Torino, Torino, Italy.
² Department of Haematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
³ Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
⁴ Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
⁵ Nuclear Medicine, San Giovanni Battista Hospital and University of Torino, Torino, Italy.

No abstract available

Keywords: cell biology; chronic lymphocytic leukaemia; prognostic factors; telomere.

Publication types